Literature DB >> 28919082

Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Guido Eibl, Zobeida Cruz-Monserrate, Murray Korc, Maxim S Petrov, Mark O Goodarzi, William E Fisher, Aida Habtezion, Aurelia Lugea, Stephen J Pandol, Phil A Hart, Dana K Andersen.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest types of cancer. The worldwide estimates of its incidence and mortality in the general population are eight cases per 100,000 person-years and seven deaths per 100,000 person-years, and they are significantly higher in the United States than in the rest of the world. The incidence of this disease in the United States is more than 50,000 new cases in 2017. Indeed, total deaths due to PDAC are projected to increase dramatically to become the second leading cause of cancer-related deaths before 2030. Considering the failure to date to efficiently treat existing PDAC, increased effort should be undertaken to prevent this disease. A better understanding of the risk factors leading to PDAC development is of utmost importance to identify and formulate preventive strategies. Large epidemiologic and cohort studies have identified risk factors for the development of PDAC, including obesity and type 2 diabetes mellitus. This review highlights the current knowledge of obesity and type 2 diabetes as risk factors for PDAC development and progression, their interplay and underlying mechanisms, and the relation to diet. Research gaps and opportunities to address this deadly disease are also outlined.
Copyright © 2018 Academy of Nutrition and Dietetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Obesity; Pancreatic cancer; Prevention; Review; Type 2 diabetes mellitus

Mesh:

Year:  2017        PMID: 28919082      PMCID: PMC5845842          DOI: 10.1016/j.jand.2017.07.005

Source DB:  PubMed          Journal:  J Acad Nutr Diet        ISSN: 2212-2672            Impact factor:   4.910


  185 in total

1.  A mouse model of diet-induced obesity and insulin resistance.

Authors:  Chao-Yung Wang; James K Liao
Journal:  Methods Mol Biol       Date:  2012

2.  Abdominal adiposity and risk of pancreatic cancer.

Authors:  Thomas C Kwee; Robert M Kwee
Journal:  Pancreas       Date:  2007-10       Impact factor: 3.327

Review 3.  A decade of progress in adipose tissue macrophage biology.

Authors:  Andrea A Hill; W Reid Bolus; Alyssa H Hasty
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

Review 4.  The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA.

Authors:  Elizabeth Oliver; Fiona McGillicuddy; Catherine Phillips; Sinead Toomey; Helen M Roche
Journal:  Proc Nutr Soc       Date:  2010-02-17       Impact factor: 6.297

Review 5.  Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells.

Authors:  Minoti V Apte; Jeremy S Wilson
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

6.  Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways.

Authors:  Eva C Vaquero; Mouad Edderkaoui; Kyung J Nam; Ilya Gukovsky; Stephen J Pandol; Anna S Gukovskaya
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

7.  Pancreatic stellate cells: partners in crime with pancreatic cancer cells.

Authors:  Alain Vonlaufen; Swapna Joshi; Changfa Qu; Phoebe A Phillips; Zhihong Xu; Nicole R Parker; Cheryl S Toi; Romano C Pirola; Jeremy S Wilson; David Goldstein; Minoti V Apte
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 8.  Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Lapo Bencini; Andrea Galli
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

Review 9.  Inflammation and pancreatic cancer: an evidence-based review.

Authors:  Julia B Greer; David C Whitcomb
Journal:  Curr Opin Pharmacol       Date:  2009-07-07       Impact factor: 5.547

10.  Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor-1-dependent manner.

Authors:  Alison E Harvey; Laura M Lashinger; Drew Hays; Lauren M Harrison; Kimberly Lewis; Susan M Fischer; Stephen D Hursting
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more
  33 in total

1.  Relationship between circulating levels of pancreatic proteolytic enzymes and pancreatic hormones.

Authors:  Sakina H Bharmal; Sayali A Pendharkar; Ruma G Singh; Mark O Goodarzi; Stephen J Pandol; Maxim S Petrov
Journal:  Pancreatology       Date:  2017-09-20       Impact factor: 3.996

2.  Pancreatic Cancer Incidence, Mortality, and Survival in Puerto Rico, 2001-2015.

Authors:  M Castañeda-Avila; C R Torres-Cintrón; A Cruz-Benítez; W Fuentes-Payán; A Maldonado-Albertorio; L Nieves-Ferrer; P Padró-Juarbe; R Soto-Abreu; N Perez-Ríos; K J Ortiz-Ortiz; P Magno; A P Ortiz
Journal:  P R Health Sci J       Date:  2019-09       Impact factor: 0.705

3.  Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort.

Authors:  Veronica Wendy Setiawan; Daniel O Stram; Jacqueline Porcel; Suresh T Chari; Gertraud Maskarinec; Loïc Le Marchand; Lynne R Wilkens; Christopher A Haiman; Stephen J Pandol; Kristine R Monroe
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

4.  Pathogenesis of Pancreatic Cancer-Related Diabetes Mellitus: Quo Vadis?

Authors:  Murray Korc
Journal:  Pancreas       Date:  2019 May/Jun       Impact factor: 3.327

5.  Parental obesity programs pancreatic cancer development in offspring.

Authors:  Raquel Santana da Cruz; Johan Clarke; Ana Cristina P Curi; Aseel Al-Yawar; Lu Jin; Ali Baird; M Idalia Cruz; Bhaskar Kallakury; Sonia de Assis
Journal:  Endocr Relat Cancer       Date:  2019-05       Impact factor: 5.678

6.  Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma.

Authors:  Anna Evans Phillips; Nilesh Shah; Amir A Borhani; Dhiraj Yadav; Randall E Brand
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

Review 7.  Carcinogenesis of Pancreatic Ductal Adenocarcinoma.

Authors:  Peter Storz; Howard C Crawford
Journal:  Gastroenterology       Date:  2020-03-19       Impact factor: 22.682

Review 8.  KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Semin Cancer Biol       Date:  2017-10-24       Impact factor: 15.707

9.  African-Americans and Indigenous Peoples Have Increased Burden of Diseases of the Exocrine Pancreas: A Systematic Review and Meta-Analysis.

Authors:  Aya Cervantes; Ellen K Waymouth; Maxim S Petrov
Journal:  Dig Dis Sci       Date:  2018-09-27       Impact factor: 3.199

10.  KRAS Controls Pancreatic Cancer Cell Lipid Metabolism and Invasive Potential through the Lipase HSL.

Authors:  Cody N Rozeveld; Katherine M Johnson; Lizhi Zhang; Gina L Razidlo
Journal:  Cancer Res       Date:  2020-08-19       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.